Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Alexandre Pérez-López"'
Autor:
Alexandre Pérez-López, Cristina Martín-Sabroso, Ana Isabel Torres-Suárez, Juan Aparicio-Blanco
Publikováno v:
Pharmaceutics, Vol 12, Iss 11, p 1028 (2020)
Over the past few decades, the field of cancer therapy has seen a significant change in the way in which formulations are designed and developed, resulting in more efficient products that allow us to ultimately achieve improved drug bioavailability,
Externí odkaz:
https://doaj.org/article/575150abad5e404183df1229cb1163f7
Autor:
Alexandre Pérez-López, Ana Isabel Torres-Suárez, Cristina Martín-Sabroso, Juan Aparicio-Blanco
Publikováno v:
Advanced Drug Delivery Reviews. 196:114816
Publikováno v:
Anales de la Real Academia Nacional de Farmacia. :35-51
The consumption of opioid analgesics has increased drastically in the last decades worldwide. This high consumption is linked with a surge in the number of opioid prescriptions for the treatment of chronic pain and a surge in opioid misuse and addict
Autor:
Alexandre Pérez-López, Cristina Martín-Sabroso, Laura Gómez-Lázaro, Ana Isabel Torres-Suárez, Juan Aparicio-Blanco
Publikováno v:
E-Prints Complutense. Archivo Institucional de la UCM
instname
instname
Embolization with microspheres is a therapeutic strategy based on the selective occlusion of the blood vessels feeding a tumor. This procedure is intraarterially performed in the clinical setting for the treatment of liver cancer. The practice has ev
Autor:
Juan Aparicio-Blanco, Cristina Martín-Sabroso, Alexandre Pérez-López, Beatriz Tapias-Frutos, Sofía Negro-Álvarez, Damián Córdoba-Díaz, Ana Isabel Fraguas-Sánchez, Ana Fernández-Carballido, Emilia Barcia-Hernández, Sandra Catalán, Rafael Rodríguez-Sánchez, Ana Isabel Torres-Suárez
Publikováno v:
INTED2022 Proceedings.
Autor:
Juan Aparicio-Blanco, Ana Isabel Torres-Suárez, Cristina Martín-Sabroso, Alexandre Pérez-López
Publikováno v:
Pharmaceutics
Pharmaceutics, Vol 12, Iss 1028, p 1028 (2020)
Pharmaceutics, Vol 12, Iss 1028, p 1028 (2020)
Over the past few decades, the field of cancer therapy has seen a significant change in the way in which formulations are designed and developed, resulting in more efficient products that allow us to ultimately achieve improved drug bioavailability,